To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Searle Responds to Journal Report On Celebrex Side Effects URL: http://www.pslgroup.com/dg/F8F2E.htm Doctor's Guide April 22, 1999
SKOKIE, Ill. -- April 22, 1999 -- A leading U.S. rheumatologist says there is no evidence in an adverse event report submitted to the U.S. Food and Drug Administration to indicate that there is any danger in using the new arthritis drug, Celebrex(TM) (celecoxib). "After review of the individual cases, I believe there is nothing in the adverse event report that should concern patients," Dr. Lee Simon, a leading rheumatologist from Harvard Medical School, said in a statement released by G.D. Searle, maker of Celebrex. "I will continue to prescribe Celebrex, and patients can continue to use Celebrex with confidence, consistent with their physicians' advice." G.D. Searle issued the statement in response to a Wall Street Journal story about adverse events among patients taking Celebrex. The statement said the company's first interest is patient safety. "We take all adverse reaction reports seriously, review them appropriately, and share information with the Food and Drug Administration (FDA)," the statement says. According to the company, Searle's medical review of the individual 10 reports reported by the Journal indicates no direct causality between Celebrex usage and any of the reported deaths. "Celebrex is already being used by more than 2 million people. There is nothing in the postmarketing reports to alter our confidence in the safety and effectiveness of Celebrex. Our experience shows that the drug is safe and effective when used as prescribed within the label," the statement says. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.